BE641880A - - Google Patents

Info

Publication number
BE641880A
BE641880A BE641880A BE641880A BE641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A
Authority
BE
Belgium
Application number
BE641880A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE641880A publication Critical patent/BE641880A/xx

Links

BE641880A 1962-12-27 1963-12-27 BE641880A (enExample)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP5741963 1963-10-29
JP6427663 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
BE641880A true BE641880A (enExample) 1964-04-16

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
BE641880A BE641880A (enExample) 1962-12-27 1963-12-27

Country Status (5)

Country Link
BE (1) BE641880A (enExample)
FR (1) FR3150M (enExample)
GB (1) GB1080599A (enExample)
LU (1) LU45106A1 (enExample)
NL (1) NL302572A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
SI2153870T1 (sl) 2004-11-26 2014-05-30 Ucl Business Plc Sestavki, ki obsegajo ornitin in fenilacetat ali fenilbutirat, za zdravljenje hepatitične encefalopatije
MX2011010262A (es) 2009-04-03 2012-01-25 Ocera Therapeutics Inc Fenil acetato de l-ornitina y metodos para elaborar el mismo.
MX2011013129A (es) 2009-06-08 2012-03-14 Ucl Business Plc Tratamiento de hipertension portal y restauracion de la funcion hepatica usando fenilacetato de l-ornitina.
KR101888215B1 (ko) 2010-10-06 2018-09-20 오세라 테라퓨틱스, 아이엔씨. L-오르니틴 페닐아세테이트의 제조 방법
NZ732632A (en) 2014-11-24 2021-07-30 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
WO2017031131A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
AU2018266357B2 (en) 2017-05-11 2022-12-08 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
FR3150M (fr) 1965-02-22
GB1080599A (en) 1967-08-23
LU45106A1 (enExample) 1964-02-24
NL302572A (enExample)

Similar Documents

Publication Publication Date Title
BE616548R (enExample)
AU269855A (enExample)
BE380301A (enExample)
BE489310A (enExample)
BE538252A (enExample)
BE538831A (enExample)
BE541929A (enExample)
BE553896A (enExample)
BE559145A (enExample)
BE586180A (enExample)
BE592434A (enExample)
BE599783A (enExample)
BE604335A (enExample)
BE608197A (enExample)
BE609543A (enExample)
BE612190A (enExample)
BE612311A (enExample)
BE612464A (enExample)
BE612847A (enExample)
BE612926A (enExample)
BE613108A (enExample)
BE613190A (enExample)
BE613298A (enExample)
BE613319A (enExample)
BE613335A (enExample)